Stoke Therapeutics, Inc.STOKNASDAQ
LOADING
|||
EV to Sales: Premium Valuation
Trending higher, above historical average.
Left:
||||
Enterprise value to sales ratio
Latest
12.86
↑ 173% above average
Average (7y)
4.70
Historical baseline
Range
High:19.98
Low:0.00
Volatility
424.8%
High variability
| Period | Value | Change |
|---|---|---|
| 2024 | 12.86 | +168.6% |
| 2023 | 4.79 | -76.0% |
| 2022 | 19.98 | - |
| 2021 | 0.00 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |